Area of focus

Digital Health

As the industry forges ahead to advance the digital health ecosystem, the companies in this space will navigate a complex set of business and legal issues that are often evolving in real time. That's where Hogan Lovells can help.

Our cross-jurisdictional team of more than 50 life sciences lawyers bring a real-world sensibility to your challenges and business opportunities. We take a technology-based approach to counseling on digital health products and services and provide strategic guidance on how to leverage...

Representative experience

Multiple clients on the use of telehealth and other digital health applications to monitor COVID-19 patients in their homes.

Multiple clients – including high-technology companies – in drafting and negotiating agreements to develop and commercialize digital health products that depend on access to and exchange of data.

Multiple pharmaceutical companies on the use of software applications within a clinical trial setting.

A client on the development of a new digital health product consisting of a mobile app for the patient and web-based apps for HCPs.

A provider of advanced diagnostic imaging, outpatient, and cancer care on the generation of their digital architecture strategy through licensing, joint venture, and acquisition arrangements.

Two successful de novo applications to FDA for AI medical products. IDx's product for use in diabetic retinopathy screening and Viz.ai's product that analyzes CT angiographic images to support acute stroke care.

A leading consumer product company on the development and classification of a consumer-oriented wearable sensor and associated mobile application.

Various regulatory aspects of international telemedicine, including cross-border health care, data privacy, and medical device aspects.

Medical device manufacturers with structuring their connected medical device services to facilitate cross-border data transfers and streamline EU data protection constraints.

Multiple life sciences companies on the use of data (including patient data) from handheld devices, mobile apps, tracking, and other personal devices for various use scenarios.

Competition law aspects of blockchain technology, which is explored for use in pharmaceutical supply chain management and patient data handling.

Technology companies, as well as hospitals, health plans, and biotech companies, on issues related to the use of data in research contexts, health privacy and the cloud, and core HIPAA compliance.

Various regulatory aspects of international telemedicine, including cross-border health care, data privacy, and medical device aspects.

A global technology company in licensing its glucose monitoring "smart lens" technology, and its joint ventures to develop next-generation surgical robots and bioelectronic medicines.

An international IT company concerning the use of AI in support of medical practice, especially diagnosis of diseases, and the potential classification of related software as a medical device in the EU.

Cisco Healthcare in rolling out its telemedicine products in China and related regulatory issues.

A surgical robotic company on competition law aspects, in particular as regards market definition in fields of nascent technologies.

Loading data